Novo Nordisk A/S Stock: price and insider trades · Denmark

Headquartered in Bagsværd, Denmark, Novo Nordisk A/S belongs to the Health Care sector and traces its origins to 1923. Its latest reported headcount is 68,794 employees (2025). Filings by its managers are published through Finanstilsynet DK. Over the twelve months to 18 October 2026, 7 filings were filed, from 2 insiders.

Open-market activity splits into 1 purchase totalling €270k and 2 sales totalling €2.1M; 1 insider sit on the buying side and 1 insider on the selling side. The net balance comes to €1.8M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. member/Executive/Associated Person filed the largest sale, €1.1M, on 11 February 2026.

Across the 74 companies tracked on its exchange, the median is 4 filings; at 7 filings, this issuer sits above that mark. The full history, which starts in 2005, counts 38 purchases against 56 sales.

The most recent open-market purchase was published on 17 November 2025, 334 days ago. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by Finanstilsynet DK and describes the past, not future prices; it is not investment advice.